Over 1000 IVF Procedures are done in Delhi NCR per Day
Advertisement
New Delhi: According to the Indian Society of Assisted Reproduction, infertility affects 10 to 14 per cent of the Indian population (as of 2018). In urban areas like Delhi, one out of every six couples is reported to be affected with infertility.
The advent of assisted reproductive techniques (ART) has resulted in significant adoption of these services and driven a large demand. Delhi is emerging as the prime preferable location for Indian as well as international patients for IVF treatment.
Dr Jyoti Bali, Infertility Expert, Medical Director, Baby soon IVF & Fertility Center as well as Secretary of Delhi Chapter, Indian Society of Assisted Reproduction, Secretary, Delhi Gynaecology Forum & Women Doctor’s Wing, Indian Medical Association highlighted the fact that it has been estimated that more than 1000 IVF procedures are performed regularly in Delhi NCR region.
According to a new report of Allied Market Research (AMR), the in vitro fertility (IVF) services in India are projected to reach $775.9 million by 2022, registering a CAGR of 16.6 per cent from 2016 to 2022 opening newer avenues in the field of Assisted Reproduction Technology.
The advent of assisted reproductive techniques (ART) has resulted in significant adoption of these services and driven a large demand. Delhi is emerging as the prime preferable location for Indian as well as international patients for IVF treatment.
Dr Jyoti Bali, Infertility Expert, Medical Director, Baby soon IVF & Fertility Center as well as Secretary of Delhi Chapter, Indian Society of Assisted Reproduction, Secretary, Delhi Gynaecology Forum & Women Doctor’s Wing, Indian Medical Association highlighted the fact that it has been estimated that more than 1000 IVF procedures are performed regularly in Delhi NCR region.
According to a new report of Allied Market Research (AMR), the in vitro fertility (IVF) services in India are projected to reach $775.9 million by 2022, registering a CAGR of 16.6 per cent from 2016 to 2022 opening newer avenues in the field of Assisted Reproduction Technology.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.